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LEUKEMIA INHIBITORY FACTOR (LTF) INHIBITS 
GLYCOSAMINCLYCAN RELEASE FROM HUMAN 
ARTICULAR CARTILAGE 
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Introduction: Leukemia inhibitory factor (LIF) is detectable in 
synovial fluids from patients with rheumatoid arthritis and 
osteoarthritis (OA) (1) as well as in supenatants from cultured 
human synovium (2). In addition, LIF can stimulate glycosamino- 
glycan (GAG) release from porcine cartilage (3) and inhibit pro- 
teoglycan synthesis. The aims of this study were therefore to 
determine whether LIF can similarly alter human articular cartilage 
metabolism and thereby contribute to joint destruction. 
Methods: Cartilage was obtained from OA and non-arthritic (NA) 
patients undergoing joint replacement surgery. Cartilage biopsies 
were incubated for 14 days without (control) or with (test) specif- 
ic concentrations of LIF (lpg/ml-100ng/ml), IIc-1~ (20pg/ml) or 
TNFcc (5ng/ml), alone or in combination. GAG release from biop- 
sies into culture supernatants was measured by DMMB assay. 
Comparison was made between cumulative GAG release from 
biopsies cultured in the presence of cytokine with that from cor- 
responding control biopsies cultured in medium alone. The sig- 
nificance of the difference in GAG release from test and control 
biopsies was assessed by Student's paired t-test. 
Results: Cumulative GAG release from OA and NA cartilage 
biopsies cultured with LIF, at all concentrations tested, was lower 
than that from control biopsies. LIF (100pg/ml) significantly 
decreased GAG release from NA cartilage in one of two experi- 
ments. For OA cartilage, LIF (10ng/ml) significantly decreased 
GAG release from cartilage in 6/7 experiments (86%). IL-I~ 
(20pg/ml) and TNFa (5ng/ml) alone increased GAG release from 
OA cartilage. However, when each cytokine was combined with 
LIF (10ng/ml), GAG release from OA cartilage was significantly 
reduced. 
Discussion These results show LIF, at concentrations detected 
within OA knee joints, can inhibit GAG release from human artic- 
ular cartilage. Moreover, LIF also abrogated the effects of IL-1 
and TNFc~ on OA cartilage. These data suggest LIF may have a 
protective role in some human articular joints. 
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BIGLYCAN AND FIBROMODULIN DOUBLE KNOCKOUT 
MICE EXHIBIT COLLAGEN FIBRIL ABNORMALITIES AND 
GAIT IMPAIRMENT AND DEVELOP ECTOPIC SESAMOID 
BONES AND PREMATURE OSTEOARTHRITIS IN THEIR 
JOINTS 
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Biglycan (BGN) and fibromodulin (FM) are two extracellular small 
leucinerich proteoglycans that are co-expressed in tendon, carti- 
lage and bone. BGN-FM double-knockout mice (DKO) were gen- 
erated in order to investigate possible interactions between the 
two proteoglycans in vivo. DKO were fertile and viable, but lean- 
er than the wild-type (WT) and single knockouts. Compared with 
WT and single knockouts, 1-month old DKO exhibited a 
decreased flexibility of their knees and ankles impairing their gait. 
Radiographs of these joints revealed ectopic radiodense areas 
developing between the age of 1 and 3 months in the three 
knockout mice (a pathology never reported before in the single 
knockouts). The radiodense areas were shown by histology to be 
bones that developed through ossification of fibrocartilage that 
formed abnormally within the tendons. With age, tendon ossifica- 
tions became more widespread throughout he body. Statistical 
analyses performed on semi-quantitative scores based on radi- 
ographs showed that 1) the males were more severely affected 
than the females, 2) the ectopic ossification increased with age 
and was more severe in the DKO than in the WT and single 
knockouts and 3) the concomitant absence of BGN and FM has 
a synergistic effect on the severity of the phenotype suggesting 
an in vivo interaction between BGN and FM. Histological analysis 
also revealed osteoarthritis in the medial compartment of the 
knee starting at 3 months of age in the three knockouts, with the 
DKO being the most profoundly affected. Between 6 and 9 
months of age, bony cysts and severe cartilage loss with expo- 
sure of the underlying bone were observed in the DKO knee 
joints. To understand the mechanisms underlying the phenotype 
at the microscopic level, an electron microscopic analysis of the 
tendons was performed. It demonstrated that the morphology 
and the diameter distribution of the collagen fibrils were altered in 
the tendons of the 3 knockouts. The phenotype of the BGN-FM 
DKO showed striking similarities with the phenotype of the 
STR/ORT mice, a strain that develops pontaneous ectopic ossi- 
fication and osteoarthritis in the knee joints. We theorized that 
abnormal collagen fibrils destabilized the joints of the DKO, and 
were the common origin of the gait impairment, ectopic ossifica- 
tion and premature osteoarthritis noted in these mice. 
In summary, the BGN/FM DKO mouse constitute an important 
new animal model for osteoarthritis that in contrast o other mod- 
els is characterized by a very early onset of the disease. 
Subsequently, it will be a useful tool to unravel the molecular 
events that accompany this prevalent skeletal disease. 
PP28 
STROMAL CELL-DERIVED FACTOR-1 SIGNALING: A NOVEL 
MECHANISM OF SYNOVIAL INDUCTION OF CARTILAGE 
IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS 
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The chemokine family of secreted proteins regulates cellular 
activities through interaction with G protein-coupled chemokine 
receptors. To analyze the role of a chemokine stromal cell-derived 
factor 1 (SDF- 1) and its receptor CXCR4 in rheumatoid arthritis 
and osteoarthritis, we examined their gene expression in joint 
cartilage and synovium, and determined the effect of their inter- 
action on the release of matrix metalloproteases from chondro- 
cytes. 
Methods: The SDF-I protein levels in synovial fluid were quanti- 
fied by enzyme linked immunosorbent assay from 58 rheumatoid 
arthritis (RA) patients, 55 osteoarthritis (OA) patients, and 60 con- 
trol adults. Furthermore, the messenger RNA levels of SDF-1 and 
CXCR4 in chondrocytes and synovial fibroblasts were deter- 
mined by reverse transcriptase-polymerase chain reaction. 
Isolated human chondrocytes were stimulated with 100 ng/ml 
SDF- 1 and the response was analyzed by quantifying the release 
of matrix metalloproteases (MMP-1 and -3). 
Results 
We found that the concentration of SDF-1 in synovial fluid 
increased 257% in OA patients and 971% in RA patients in com- 
parison to normal respectively. The source of SDF-1 in synovial 
fluid was from synovium, since SDF-1 rnRNA was synthesized by 
synovial fibroblasts but not by chondrocytes. On the other hand, 
SDF-1 receptor CXCR4 was expressed by chondrocytes but not 
by synovial fibroblasts. The interaction of SDF-1, which was 
abundant in synovial fluid from RA and OA patients, with CXCR4 
positive chondrocytes resulted in a specific elevation of the 
